Exploring the impact of stage and tumor site on colorectal cancer survival: Bayesian survival modeling

Shayesteh Alinia,Samira Ahmadi,Zahra Mohammadi,Farzaneh Rastkar Shirvandeh,Mohammad Asghari-Jafarabadi,Leila Mahmoudi,Malihe Safari,Ghodratollah Roshanaei
DOI: https://doi.org/10.1038/s41598-024-54943-8
IF: 4.6
2024-02-22
Scientific Reports
Abstract:Colorectal cancer is a prevalent malignancy with global significance. This retrospective study aimed to investigate the influence of stage and tumor site on survival outcomes in 284 colorectal cancer patients diagnosed between 2001 and 2017. Patients were categorized into four groups based on tumor site (colon and rectum) and disease stage (early stage and advanced stage). Demographic characteristics, treatment modalities, and survival outcomes were recorded. Bayesian survival modeling was performed using semi-competing risks illness-death models with an accelerated failure time (AFT) approach, utilizing R 4.1 software. Results demonstrated significantly higher time ratios for disease recurrence (TR = 1.712, 95% CI 1.489–2.197), mortality without recurrence (TR = 1.933, 1.480–2.510), and mortality after recurrence (TR = 1.847, 1.147–2.178) in early-stage colon cancer compared to early-stage rectal cancer. Furthermore, patients with advanced-stage rectal cancer exhibited shorter survival times for disease recurrence than patients with early-stage colon cancer. The interaction effect between the disease site and cancer stage was not significant. These findings, derived from the optimal Bayesian log-normal model for terminal and non-terminal events, highlight the importance of early detection and effective management strategies for colon cancer. Early-stage colon cancer demonstrated improved survival rates for disease recurrence, mortality without recurrence, and mortality after recurrence compared to other stages. Early intervention and comprehensive care are crucial to enhance prognosis and minimize adverse events in colon cancer patients.
multidisciplinary sciences
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore how the survival outcomes of colorectal cancer patients are affected by the disease stage and tumor location. Specifically, the study aims to analyze the data of 284 patients diagnosed with colorectal cancer between 2001 and 2017 through the Bayesian survival modeling method, in order to understand the impact of tumors at different stages (early and advanced) and different locations (colon and rectum) on patient recurrence and mortality. The study adopts the semi - competing risks model combined with the accelerated failure time (AFT) model and uses R 4.1 software for data analysis. The results of the study show that, compared with early - stage rectal cancer, early - stage colon cancer patients have significantly higher time ratios in disease recurrence (time ratio \( \text{TR} = 1.712 \), 95% confidence interval \( 1.489 - 2.197 \)), non - recurrence death (\( \text{TR} = 1.933 \), 95% confidence interval \( 1.480 - 2.510 \)) and post - recurrence death (\( \text{TR} = 1.847 \), 95% confidence interval \( 1.147 - 2.178 \)). In addition, the disease - free survival time of advanced - stage rectal cancer patients is shorter than that of early - stage colon cancer patients. These findings emphasize the importance of early detection and effective management strategies for colon cancer, especially in improving the survival rate of early - stage colon cancer patients. Overall, through detailed statistical analysis, this study reveals the complex relationship between the survival outcomes of colorectal cancer patients and the disease stage and tumor location, providing an important reference for clinical treatment.